GC Green Cross announced on the 8th that it has signed a strategic business agreement with M monitor Inc, a POCT molecular diagnostic company, at the headquarters in Yongin, Gyeonggi-do on the 7th.
Under this agreement, the two companies will cooperate in various fields for overseas expansion of M monitor's COVID-19 diagnostic kit. GC Green Cross MS is in charge of product production and sales, and plans to promote new licenses for its own products through technology transfer.
This diagnostic kit is applied with'Isothermal Amplification Technology (LAMP)' that amplifies genes at a constant temperature without repeating heating and cooling. As a result, it is possible to shorten the analysis of the results from sample collection to within 1 hour. In addition, it is a feature of the product that the presence or absence of a virus can be immediately confirmed by the color change of the reagent.
The product line consists of two parts. These include a 'premix' kit with colorimetric technology applied and a 'real-time' kit using existing real-time monitoring equipment.
GC Green Cross MS is currently developing an ultra-sensitive COVID-19 diagnostic reagents using DNA polymerase technology targeting advanced medical countries. The rapid diagnosis product will be a good alternative to regions and countries where medical infrastructure is not sufficiently secured.
Exhibitor Data Sheet